BioMarin Pharmaceutical Inc. (BMRN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.029% |
| Hold Price * : | $56.49 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Viking Global Investors | Add 16.98% | 1,025,141 | 0.16 | |
| ≡ | Torray Funds | Buy | 78,170 | 0.69 | |
| Q2 2025 | |||||
| ≡ | Dodge & Cox Funds | Add 1.02% | 153,070 | 0.00 | |
| ≡ | Viking Global Investors | Add 13.78% | 1,488,552 | 0.24 | |
| Q1 2025 | |||||
| ≡ | Dodge & Cox Funds | Add 1.42% | 209,005 | 0.01 | |
| ≡ | Viking Global Investors | Add 2.75% | 289,509 | 0.07 | |
| Q4 2024 | |||||
| ≡ | Dodge & Cox Funds | Add 6.10% | 847,917 | 0.03 | |
| ≡ | Viking Global Investors | Add 7.76% | 757,257 | 0.16 | |
| Q3 2024 | |||||
| ≡ | Viking Global Investors | Add 38.08% | 2,689,729 | 0.69 | |
| Q2 2024 | |||||
| ≡ | Viking Global Investors | Add 10.09% | 647,276 | 0.20 | |
| ≡ | Torray Funds | Add 13.61% | 2,019 | 0.03 | |
| Q1 2024 | |||||
| ≡ | Torray Funds | Add 1.15% | 168 | 0.00 | |
| ≡ | Viking Global Investors | Add 31.23% | 1,526,834 | 0.50 | |
| Q4 2023 | |||||
| ≡ | Torray Funds | Add 3.14% | 446 | 0.01 | |
| ≡ | Viking Global Investors | Add 15.99% | 673,998 | 0.24 | |
| ≡ | Daniel Loeb - Third Point | Buy | 385,000 | 0.56 | |
| Q3 2023 | |||||
| ≡ | Viking Global Investors | Add 1.41% | 58,671 | 0.02 | |
| ≡ | Torray Funds | Add 29.51% | 3,241 | 0.05 | |
| Q2 2023 | |||||
| ≡ | Torray Funds | Add 0.96% | 104 | 0.00 | |
| ≡ | Viking Global Investors | Add 91.68% | 1,988,168 | 0.71 | |
| Q1 2023 | |||||
| ≡ | Torray Funds | Add 0.40% | 43 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Viking Global Investors | Add 3.42% | 174,456 | 0.09 | |
| Q3 2022 | |||||
| ≡ | Viking Global Investors | Add 0.92% | 46,571 | 0.02 | |
| Q2 2022 | |||||
| ≡ | Viking Global Investors | Add 34.65% | 1,300,200 | 0.49 | |
| Q1 2022 | |||||
| ≡ | Viking Global Investors | Add 30.75% | 882,446 | 0.28 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Buy | 2,869,947 | 0.74 | |
| Q3 2021 | |||||
| ≡ | Torray Funds | Add 1.26% | 204 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Torray Funds | Add 0.88% | 142 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 6,480 | 0.01 | |
| Q3 2020 | |||||
| ≡ | Torray Funds | Add 26.48% | 14,320 | 0.20 | |
| Q1 2020 | |||||
| ≡ | Torray Funds | Add 7.14% | 4,037 | 0.08 | |
| Q3 2019 | |||||
| ≡ | Torray Funds | Add 0.47% | 954 | 0.01 | |
| ≡ | Viking Global Investors | Add 18.06% | 467,753 | 0.16 | |
| Q1 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Buy | 104,856 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.